Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the time it has taken you to ...

COPD exacerbations apart from making you feel terrible for a few days, there is a risk that it could end up leading to a hospitalization. Which is obviously a concerning outcome where you may need ...

In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms and decrease ...

The problem with COPD is you have obstruction ... is to keep them from having exacerbations of their disease. What I usually tell patients to look for in a flare-up is: Is their mucus getting ...

The trick is finding the right treatment plan for you ... you’re having what’s called a COPD flare-up or exacerbation. “You go from feeling crappy to feeling really crappy,” Dr ...

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations ... only head-to-head trial to date. It is reasonable to recommend ...